Abstract. We describe a patient with African tick-bite fever who acquired his infection while visiting rural areas of South Africa and then became sick after returning to the United States. The dominant clinical feature of his illness was the presence of multiple, ulcerated lesions (tache noires). Physicians in the United States and other non-African countries who see travelers returning from southern parts of Africa who give a history of recent tick bite and/or present with multiple, crusted or vesicular skin lesions should be alert to this diagnosis and institute treatment with doxycycline.
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African tick-bite fever (ATBF) is caused by Rickettsia africae, a spotted fever group rickettsia that is transmitted by infected cattle ticks (Ambylomma hebraeum) in rural areas of southern Africa. Although the distinctive clinical features of ATBF have been known to physicians practicing in southern Africa for approximately 60 years, it was erroneously assumed to be due to R. conorii until 1992 when Kelly and others isolated R. africae from a patient from Zimbabwe with ATBF. 1 Since then, several investigators have re-examined the clinical and epidemiologic features of ATFB using case definitions based on modern and highly accurate laboratory methods. 2, 3 Brouqui and others recently described seven French patients with ATBF who acquired their illness in southern Africa and returned to Europe during the incubation period of their illness. 2 Once in their homeland, they manifested an illness that was initially unfamiliar to their French physicians. Brouqui and others also suggested that the authors of previous reports of R. conorii infection in American travelers to southern Africa may, in fact, have actually described R. africae infection. [4] [5] [6] [7] [8] In May 1998, a similar cluster of ATBF cases involving nine persons returning to Oregon from a group trip to Swaziland was reported. 9 We report a serologically confirmed case of ATBF in an American traveler to South Africa to confirm that imported cases of ATBF occasionally occur in the United States and to alert other physicians to the clinical and epidemiologic features of this distinctive illness.
CASE REPORT
On May 18, 1997, a 66-year-old previously healthy physician removed several ticks from his body while hunting near Kruger National Park in South Africa. The following day he returned to the United States. On August 20, 1997, he noticed five discrete red lesions on his arms and back. Over the next three days, these lesions ulcerated and formed discrete eschars (Figure 1 ). He developed minimal generalized aching and fatigue simultaneous with the appearance of these skin lesions, which he ascribed to the 24-hr flight home. He did not have fever, chills, anorexia, or significant malaise. When first seen on August 25, 1997, one new vesicular red lesion was present on his forearm, but the remainder of his physical examination showed normal results. African tick bite fever was suspected. Therapy with oral doxycycline (200 mg twice a day) was begun. During the next 72 hr, the skin lesions began to heal; full recovery occurred within five days. The skin lesions eventually healed without scarring. Acute and convalescent serum samples were tested for antibodies against R. africae using a microimmunofluorescent antibody technique. 3 IgM antibodies were undetectable in the acute serum sample and increased to a titer of 1:64 in the convalescent serum sample; IgG antibody titers to the same antigens were 1:32 and 1:64, respectively. Antibodies specific for R. africae were detected in the convalescent serum but not the acute serum sample using a Western blot technique. 3 
DISCUSSION
During the 1930s, Pijper and others described the clinical features of ATBF, isolated a causative organism from ticks, and concluded that ATBF was a separate disease from Boutonneuse fever (which at the time was known to be caused by R. conorii). [10] [11] [12] However, subsequent experiments by Gear failed to confirm these findings; thus, for the next 52 years, causes of ATBF were erroneously assumed to be due to R. conorii, a spotted fever group rickettsiae that is present in the same geographic areas as R. africae. 13 In 1990, Kelly and Mason demonstrated that spotted fever group rickettsiae isolated from A. hebraeum ticks in Zimbabwe were different from R. conorii. 14 In 1992, Kelly and others isolated R. africae from a patient with an illness typical of ATBF. 1 After using a variety of modern molecular methods such as 16S ribosomal RNA gene sequencing that compared their isolate to earlier isolates from A. hebraeum ticks, Kelly and others proposed that this organism be designated as a new species called R. africae. 15, 16 Since then, there have been several reports describing the clinical and epidemiologic features of a number of patients with laboratory-confirmed ATBF. 2, 3 The authors of the above clinical reports emphasized that ATBF is characteristically a mild disease. Multiple ulcerated skin lesions (tache noires) as seen in our patient (Figure 1 ) are the hallmark of the illness. An eruptive maculopapular or generalized petechial rash, which appears after 1-5 days of specific symptoms, typical of most other spotted fever rickettsioses, is not present in most patients with ATBF. Some patients with ATBF also develop inflammatory papules that may vesiculate (Figure 1) . Most, but not all patients with ATBF have regional lymphadenopathy and fever, findings that were not present in our patient. However, our patient was similar to many previously reported cases in that he recalled having multiple tick bites and recognized that his skin lesions appeared at the site of these bites.
The average incubation period for ATBF is six days. Thus, as illustrated in our case, it is easy for patients to acquire illness in southern Africa and then manifest their first symptoms of illness after traveling to another destination thousands of miles away.
A diagnosis of ATBF is best established using serologic tests. Since serologic cross-reactions occur between R. africae and R. conorii, additional diagnostic procedures such as cross-absorption studies or Western blotting should be performed. 17 In addition, genomic amplification by polymerase chain reaction techniques is a sensitive and specific way to detect R. conorii or R. africae in biopsies of skin lesions or other tissues. 3, 18, 19 Skin biopsy can also be used to detect rickettsiae in endothelial cells using immunofluorescence of immunoperoxidase methods. 20 The treatment of R. conorii and R. africae infection is identical. Although the clinical features of both diseases overlap to a considerable degree, ATBF may be clinically distinguishable from R. conorii infection because it is usually a milder disease, manifests as multiple tache noires, and usually presents without a rash. Recent studies have shown that ATBF is a common disease in southern Africa. 21, 22 Thus, physicians in the United States who see travelers returning from southern Africa who give a history of recent tick bite and/or present with multiple crusted or vesicular skin lesions should be alert to this diagnosis and institute treatment with doxycycline promptly if ATBF or another imported rickettsial disease is considered likely or even possible.
